These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31111824)

  • 1. Synergy between serum amyloid A and secretory phospholipase A
    Jayaraman S; Fändrich M; Gursky O
    Elife; 2019 May; 8():. PubMed ID: 31111824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid clearance and amyloid formation by serum amyloid A: exploring the links between beneficial and pathologic actions of an enigmatic protein.
    Jayaraman S; Urdaneta A; Bullitt E; Fändrich M; Gursky O
    J Lipid Res; 2023 Sep; 64(9):100429. PubMed ID: 37604227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA2-IIE and sPLA2-V Expression in Macrophages.
    Zhu S; Wang Y; Chen W; Li W; Wang A; Wong S; Bao G; Li J; Yang H; Tracey KJ; D'Angelo J; Wang H
    PLoS One; 2016; 11(11):e0167468. PubMed ID: 27898742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
    Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.
    Pruzanski W; de Beer FC; de Beer MC; Stefanski E; Vadas P
    Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):461-4. PubMed ID: 7542869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of immunity by the secreted phospholipase A
    Murakami M; Sato H; Taketomi Y
    Immunol Rev; 2023 Aug; 317(1):42-70. PubMed ID: 37035998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response.
    Frame NM; Jayaraman S; Gantz DL; Gursky O
    J Struct Biol; 2017 Dec; 200(3):293-302. PubMed ID: 28645735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted Phospholipase A
    Yamamoto K; Miki Y; Sato H; Murase R; Taketomi Y; Murakami M
    Methods Enzymol; 2017; 583():101-117. PubMed ID: 28063487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL.
    Pruzanski W; Stefanski E; de Beer FC; de Beer MC; Vadas P; Ravandi A; Kuksis A
    J Lipid Res; 1998 Nov; 39(11):2150-60. PubMed ID: 9799801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.
    Gursky O
    Curr Atheroscler Rep; 2020 Sep; 22(11):69. PubMed ID: 32968930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
    Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
    Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of secreted phospholipase A2 enzymes: the 3rd edition.
    Murakami M; Taketomi Y; Miki Y; Sato H; Yamamoto K; Lambeau G
    Biochimie; 2014 Dec; 107 Pt A():105-13. PubMed ID: 25230085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted phospholipase A2 and mast cells.
    Murakami M; Taketomi Y
    Allergol Int; 2015 Jan; 64(1):4-10. PubMed ID: 25572553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of the Secreted Phospholipase A
    Murakami M; Yamamoto K; Miki Y; Murase R; Sato H; Taketomi Y
    Adv Immunol; 2016; 132():91-134. PubMed ID: 27769509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid A sequesters diverse phospholipids and their hydrolytic products, hampering fibril formation and proteolysis in a lipid-dependent manner.
    Jayaraman S; Gantz DL; Haupt C; Fändrich M; Gursky O
    Chem Commun (Camb); 2018 Apr; 54(28):3532-3535. PubMed ID: 29565436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X.
    Pruzanski W; Kopilov J; Kuksis A
    Prostaglandins Other Lipid Mediat; 2016 Jan; 122():64-8. PubMed ID: 26711221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein.
    Santoso A; Kaniawati M; Bakri S; Yusuf I
    Int J Angiol; 2013 Mar; 22(1):49-54. PubMed ID: 24436584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.
    Curcic S; Holzer M; Frei R; Pasterk L; Schicho R; Heinemann A; Marsche G
    Biochim Biophys Acta; 2015 Feb; 1851(2):184-93. PubMed ID: 25463476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
    Murakami M; Kudo I
    Curr Opin Lipidol; 2003 Oct; 14(5):431-6. PubMed ID: 14501581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.